Aquestive Therapeutics, Inc. - Common Stock, Par Value $0.001 Per Share (AQST)

CUSIP: 03843E104

Q1 2021 13F Holders as of 31 Mar 2021

Holder snapshot 7 signals
Share change
-2,510,608
Put/Call ratio
244%
SEC-reported price per share
$5.20
Number of holders
62
Value change
-$13,347,120
Number of buys
29
Open additional details 1 more signal available
Number of sells
33
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
125,140,813

Security key

03843E104

Report period

Q1 2021

Institutions

62

Top holders

10

Ownership snapshot

Top reported holders of AQST - Aquestive Therapeutics, Inc. - Common Stock, Par Value $0.001 Per Share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Bratton Capital Managemen...
Disclosed value leader
Bratton Capital Managemen...
Comparable rows
0/15
Latest evidence
31 Dec 2020
13F Highest disclosed value: $61,543,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Bratton Capital Management, L.P. has the largest disclosed position value at $61.54M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Bratton Capital Management, L.P.'s linked filing trail.
Disclosed position value Top 5
Bratton Capital Management, L.P. $61.54M
PERCEPTIVE ADVISORS LLC $7.41M
BlackRock Finance, Inc. $6.98M
VANGUARD GROUP INC $4.78M
Nuveen Asset Management, LLC $2.84M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Bratton Capital Management, L.P.
13F
Company
13F
—
denominator unverified
$61,543,000
11,503,294 shares
— 31 Dec 2020
PERCEPTIVE ADVISORS LLC
13F
Company
13F
—
denominator unverified
$7,414,000
1,385,720 shares
— 31 Dec 2020
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$6,985,000
1,305,838 shares
— 31 Dec 2020
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$4,785,000
894,395 shares
— 31 Dec 2020
Nuveen Asset Management, LLC
13F
Company
13F
—
denominator unverified
$2,842,000
531,086 shares
— 31 Dec 2020
Bracebridge Capital, LLC
13F
Company
13F
—
denominator unverified
$2,293,000
428,571 shares
— 31 Dec 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
62
Shares
16,607,064
Rows available
62
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2021 vs Q1 2021 Across Filers

Q1 2021 holders
62
Q1 2021 holders
62
Holder diff
0
Investor Q1 2021 Shares Q1 2021 Shares Share Diff Share Chg % Q1 2021 value Q1 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .